glp-1 and hs Translated article] Glucagon-Like Peptide-1 Agonists for Treating Obesity in Patients With Immune-Mediated Skin Diseases GLP-1-based therapies for type 2
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
![glp-1 and hs Translated article] Glucagon-Like Peptide-1 Agonists for Treating Obesity in Patients With Immune-Mediated Skin Diseases GLP-1-based therapies for type 2](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs13098-025-01623-w/MediaObjects/13098_2025_1623_Figa_HTML.png)
![glp-1 and hs Translated article] Glucagon-Like Peptide-1 Agonists for Treating Obesity in Patients With Immune-Mediated Skin Diseases GLP-1-based therapies for type 2](https://d1svk58pjf7hyt.cloudfront.net/wp-content/uploads/sites/6/2025/08/glp-1-related-drugs-newspaper-headlines-with-hand-and-magnifying-glass.jpg_s1024x1024wisk20cMoQiMaTcvgt0k7QrvGBm-uWiSZ84SBcImlz_uGLooHM.jpg)
![glp-1 and hs Translated article] Glucagon-Like Peptide-1 Agonists for Treating Obesity in Patients With Immune-Mediated Skin Diseases GLP-1-based therapies for type 2](https://www.emjreviews.com/wp-content/uploads/2025/08/9am-Derm-5.jpg)
![glp-1 and hs Translated article] Glucagon-Like Peptide-1 Agonists for Treating Obesity in Patients With Immune-Mediated Skin Diseases GLP-1-based therapies for type 2](https://www.mdpi.com/jcm/jcm-15-02909/article_deploy/html/images/jcm-15-02909-g002-550.jpg)
![glp-1 and hs Translated article] Glucagon-Like Peptide-1 Agonists for Treating Obesity in Patients With Immune-Mediated Skin Diseases GLP-1-based therapies for type 2](https://cdn.sanity.io/images/0vv8moc6/ajmc/9e6d9d679e0aa304ec9724d2d34c630027fbdca8-7500x3500.jpg)
![glp-1 and hs Translated article] Glucagon-Like Peptide-1 Agonists for Treating Obesity in Patients With Immune-Mediated Skin Diseases GLP-1-based therapies for type 2](https://jcadonline.com/wp-content/uploads/Cotter2_Table2.gif)


















